TOBRADEX [tobramycin/dexamethasone] ophthalmic suspension versus tobramycin 0.3 percent/dexamethasone 0.05 percent ophthalmic suspension.
Phase of Trial: Phase III
Latest Information Update: 26 Mar 2010
At a glance
- Drugs Dexamethasone; Tobramycin; Tobramycin/dexamethasone
- Indications Bacterial infections; Blepharoconjunctivitis
- Focus Therapeutic Use
- Sponsors Alcon
- 15 Jan 2010 Actual end date (March 2008) added as reported by ClinicalTrials.gov.
- 15 Jan 2010 Actual patient number (221) added as reported by ClinicalTrials.gov.
- 24 Mar 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov